跳至主要内容
临床试验/JPRN-UMIN000013870
JPRN-UMIN000013870招募中未知

Phase II Trial of Balloon Occluded Transarterial Chemoembolization with Epirubicin and Ethiodized Oil for Large Advanced Hepatocellular Carcinomas of the Barcelona Clinic Liver Cancer Stage B - B-TACE Large Study

Department of Radiology, Juntendo University Hospital0 个研究点目标入组 27 人开始时间: 2014年5月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Extrahepatic metastasis. 2) Diagnostic or suspicious lesion of Portal venous invasion, hepatic venous invasion or bile duct invasion. 3) Post ruputred state of hepatocellular carcinoma 4) Remarkable arterio-portal or arterio-venous shunting. 5) Hepatic artery occlusion or major extrahepatic collaterals interfering effective drug delivery. 6) Post biliary reconstruction state. 7) Refractory ascites or pleural effusion. 8) Comorbid diseases as cardiac failure, renal failure, active infection, active gastrointestinal bleeding, active associated cancers, hepatic encephalopathy or uncontrolled psychologic disorders. 9) Fever (more than 38 degrees Celsius) 10) Allergy to contrast media or anthracycline agents. 11) Pregnant or lactating. 12) Other reasons not indicated to this study judged by doctors.

研究者

发起方
Department of Radiology, Juntendo University Hospital

相似试验